Australian hearing device emphasizes discreet aid

A new discreet hearing aid by Australia-based Cochlear Limited is set to enter the market this fall.

The new Kanso Sound Processor is an off-the-ear hearing device designed to deliver the same quality of hearing as other behind-the-ear products. ("Kanso" means simplicity in Japanese.)

The wireless device has only a single on/off button, dual microphones and can be easily hidden under or blended within hair, Cochlear said in a statement. It will come in eight colors.

“Through customer feedback, we identified the need for a new solution that provides the advanced technology and hearing performance of our latest cochlear implant sound processor, which is worn behind the ear, in an easy and discreet design with access to wireless and water accessories, all without losing the high-quality hearing experience our customers expect from our products,” said Tony Manna, president of Cochlear North America, in a statement.

The Kanso Sound Processor was designed with the same technology used in other Cochlear devices like the Nucleus 6 Sound Processor, which allows the processor to automatically adjust to different listening environments. The Kanso model also has built-in wireless streaming technology so that users can take calls, listen to music and connect it to video viewing devices.

 

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”